(Q45377408)

English

Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies

scientific article published on 20 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1 reference

based on heuristic

inferred from title

Martin F. Bachmann

7

object named as

Martin F Bachmann

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Philippe Saudan

6

object named as

Philippe Saudan

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Andrea Jegerlehner

1

object named as

Andrea Jegerlehner

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

author name string

Melanie Wiesel

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Klaus Dietmeier

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Franziska Zabel

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Dominique Gatto

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

language of work or name

0 references

publication date

20 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

5503-5512

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Epitope-specific regulation. II. A bistable, Igh-restricted regulatory mechanism central to immunologic memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Prior immunity to a carrier enhances antibody responses to hCG in recipients of an hCG-carrier conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Effect of priming with carrier on response to conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Adjuvant/carrier activity of inactivated tick-borne encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Designing recombinant vaccines with viral properties: a rational approach to more effective vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

A virus-like particle-based vaccine selectively targeting soluble TNF-alpha protects from arthritis without inducing reactivation of latent tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Protection against osteoporosis by active immunization with TRANCE/RANKL displayed on virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Regulatory T cells under scrutiny

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Studies on antigen-antibody complexes. I. Elimination of soluble complexes from rabbit circulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Primate erythrocyte-immune complex-clearing mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Fc receptor biology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Mechanisms of phagocytosis in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

The antiviral activity of antibodies in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Antibodies against viruses: passive and active immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Fcgamma receptors as regulators of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

FcγRIIb controls bone marrow plasma cell persistence and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

B-cell memory: are subsets necessary?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Can successful vaccines teach us how to induce efficient protective immune responses?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of preimmunization with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.103

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.02.103

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

release_wqmbf65v2rhhtgs4m5kkpheug4

1 reference

https://api.fatcat.wiki/v0/release/wqmbf65v2rhhtgs4m5kkpheug4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45377408&oldid=2076258669"